A recall of generic losartan tablets distributed by Teva Pharmaceuticals has been expanded after investigators detected high levels of NMBA in additional lots.…
In July 2018, it was discovered that certain generic valsartan pills sold for years may contain impurities that increase the risk of users developing liver cancer, kidney cancer and other side effects. …
Teva Pharmaceuticals is recalling 35 lots of losartan potassium hypertension pills because they tested positive for a cancer-causing impurity.…
A ParaGard uterus perforation lawsuit was dismissed after a federal judge ruled that Teva had provided adequate warnings of the potential risks of surgical complications.…
A valsartan recall lawsuit claims that years of using the hypertension drugs led to a case of colon cancer.…
A valsartan class action lawsuit claims manufacturers sold hypertension drugs to consumers that were toxic and carried a cancer risk.…
Teva issued a nationwide recall this week affecting all of its generic Amlodipine/Valsartan combination tablets and Amlodipine/Valsartan/Hydrochlorothiazide combination tablets due to the presence of NDEA.…
A valsartan class action lawsuit filed by a Texas man accuses several manufacturers of knowing the drugs might be contaminated years before recalls were announced.…
European health experts estimate that 1 in 5,000 long-term users of recalled valsartan drugs could develop cancer because of exposure to NDMA.…
The FDA is expanding a valsartan recall and warning that additional products may be recalled in the coming days over fears that the blood pressure medications are contaminated with a cancer-causing impurity.…
